Continental Investors Services’s Idexx Laboratories IDXX Stock Holding History

Continental Investors Services’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$630K	Hold	1,077	–	–	0.49%	38
2026 Q1	$573K	Hold	1,077	–	–	0.54%	42
2025 Q4	$722K	Sell	1,077 -6	-0.6%	-$4.09K	0.93%	30
2025 Q3	$688K	Sell	1,083 -10	-0.9%	-$6.07K	1.02%	30
2025 Q2	$586K	Hold	1,093	–	–	1.05%	27
2025 Q1	$459K	Hold	1,093	–	–	0.91%	31
2024 Q4	$452K	Hold	1,093	–	–	0.9%	33
2024 Q3	$541K	Hold	1,093	–	–	1.11%	27
2024 Q2	$533K	Hold	1,093	–	–	1.19%	25
2024 Q1	$582K	Hold	1,093	–	–	1.38%	22
2023 Q4	$607K	Hold	1,093	–	–	1.58%	19
2023 Q3	$478K	Sell	1,093 -1,093	-50%	-$545K	1.45%	18
2023 Q2	$1.16M	Buy	2,186 +1,093	+100%	+$524K	1.37%	16
2023 Q1	$547K	Hold	1,093	–	–	1.55%	15
2022 Q4	$446K	Hold	1,093	–	–	1.39%	18
2022 Q3	$356K	Hold	1,093	–	–	1.07%	21
2022 Q2	$383K	Hold	1,093	–	–	1.12%	21
2022 Q1	$720K	Hold	1,093	–	–	1.89%	14
2021 Q4	$598K	Buy	+1,093	New	+$686K	1.59%	15

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Continental Investors Services's IDXX Position: Q2 2026 in Review

Continental Investors Services held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 1,077 shares worth $630K. The position accounts for 0.49% of the portfolio, ranked #38.

Continental Investors Services first reported a position in IDXX in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.16M in Q2 2023. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Continental Investors Services held 1,077 shares of Idexx Laboratories worth $630K as of Q2 2026.
Continental Investors Services left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.49% of Continental Investors Services's portfolio in Q2 2026, its #38 holding.
Continental Investors Services first reported a position in Idexx Laboratories in Q4 2021 and has held it in 19 quarters since.
Continental Investors Services's Idexx Laboratories position peaked at $1.16M in Q2 2023.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Continental Investors Services's 13F filing for Q2 2026, filed 13 Aug 2026.